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Prosthetic graft remnant–related pseudoaneurysm after left ventricular
assist device explantation: A case report
Gregory N. Messner, DO, Chayanin Vatcharasiritham, MD, Igor Gregoric, MD, Branislav Radovancevic, MD,
Peggy Odegaard, RN, Scott D. Flamm, MD, and O. H. Frazier, MD, Houston, Tex
Pseudoaneurysm of the ascending aorta is a rare but severe complication of cardiacsurgery. Most cases occur after coronary artery bypass grafting (CABG) and aorticvalvular procedures, and many others occur after cardiac transplantation. Thus far,the only reported case of a pseudoaneurysm related to a left ventricular assist device
(LVAD) is a pseudoaneurysm related to the prosthetic graft itself.1 We report here the first
case of a pseudoaneurysm related to LVAD explantation.
Clinical Summary
In December 1999, a 47-year-old woman with a history of progressive dyspnea on exertion
presented with a syncopal episode. She was admitted to a local hospital, where congestive
heart failure was diagnosed. Echocardiography revealed an ejection fraction of 10%. The
patient was transferred to St Luke’s Episcopal Hospital for further evaluation and treatment.
There she underwent placement of an intra-aortic balloon pump, followed by simultaneous
implantation of an LVAD (Thoratec VAD; Thoratec Corporation, Pleasanton, Calif) and
performance of the Batista procedure. Three months later, in February 2000, the patient’s
condition had improved to the point that the LVAD could be removed. Immediately after its
removal, the patient experienced postoperative bleeding that required mediastinal exploration
to control. The patient’s sternum was closed 1 day later. The patient did well for almost 1
year, until she complained of a painful swelling of the upper sternum. A computed tomog-
raphy (CT) scan of the chest showed fluid anterior and posterior to the sternum extending
back to the margin of the ascending thoracic aorta, a finding compatible with an abscess. The
abscess was incised and drained after achievement of local anesthesia. A culture grown from
a sample of the fluid grew methicillin-resistant Staphylococcus aureus. Intravenous vanco-
mycin was instituted for 1 month. On follow-up examination, a repeat CT scan showed a
2.3-cmdiameter saccular aneurysm involving the distal ascending thoracic aorta and a
parasternal collection of fluid containing air suggestive of an abscess. The abscess was
surgically drained, and intravenous vancomycin was continued at a dosage of 0.5 g/d. Again,
a culture grown from a sample of the drained fluid grew methicillin-resistant S aureus.
Magnetic resonance angiography (MRA) was performed to confirm the diagnosis of
aneurysm of the ascending aorta. This revealed a pseudoaneurysm of the ascending aorta
measuring 2.0  2.4  3.0 cm (Figure 1). Consequently, the patient was scheduled for
resection of the pseudoaneurysm. The femoral vessels were exposed and readied for cannu-
lation, and the sternum was opened with an oscillating saw. Because the pseudoaneurysm was
adherent to the sternum, the opening of the sternum caused inadvertent entry into the
pseudoaneurysm. The femoral vessels were immediately cannulated, and femorofemoral
bypass was commenced. The patient was cooled to 18°C, and circulatory arrest combined
with retrograde cerebral perfusion was initiated. Then the sternum was slowly opened. After
reduction of the blood flow to 500 mL/min, the patient was placed in the Trendelenburg
position to prevent air embolism. The pseudoaneurysm, together with the remnant of the
prosthetic graft still attached to the ascending aorta, was resected. The pre-existing anasto-
mosis between the prosthetic graft and the ascending aorta was found to be disrupted for
about one third of its entire circumference. The disrupted portion of the anastomosis was
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resected, leaving a 3  2–cm defect at the aorta, and further
dissection of the ascending aorta was done to facilitate crossclamp-
ing. After crossclamping, the patient was warmed to 32°C and then
subjected to retrograde cerebral perfusion. The defect at the aorta
was repaired by using an oval Dacron patch. The crossclamp was
then released, and the patient was warmed to 37°C and weaned off
cardiopulmonary bypass. The sternum was left open until the next
day, when the patient was brought back to the surgical theater for
placement of an omental graft and closure of the sternum. Even
though cultures of the resected pseudoaneurysm specimen did not
grow any organisms, an antibiotic therapy regimen was instituted.
Postoperatively, the patient remained stable and was discharged
home after 2 weeks.
At 1 year of follow-up, the patient was stable with no neuro-
logic deficits. A CT scan of the chest showed normal findings and
confirmed that the Dacron patch repair was still intact (Figure 2).
The antibiotic regimen was discontinued on the recommendation
of an infectious disease consultant.
Discussion
This report documents the first case of a pseudoaneurysm related
to the removal of an LVAD. CT scanning and MRA confirmed the
diagnosis, and surgical intervention was performed to correct the
problem.
Although cardiac transplantation is the therapeutic option of
choice and currently the most frequent treatment for end-stage
heart failure, wider use of this approach has been limited by
several issues. These include fewer available donor hearts than
transplant candidates and the resultant long waiting period for an
organ. In addition, there are the usual problems of rejection faced
by all transplant recipients and the heart-specific problem of cor-
onary graft atherosclerosis, which can significantly limit the long-
term survival of heart recipients.2 During the past 2 decades,
temporary mechanical circulatory support has become a widely
accepted option for patients with intractable heart failure, partic-
ularly those awaiting cardiac transplantation. An unexpected ben-
efit of prolonged LVAD use has been improved ventricular func-
tion in patients with idiopathic and dilated cardiomyopathies. In a
few cases in which LVAD removal was necessitated by device
failure or device-related infection, the patient’s native cardiac
function had recovered sufficiently to avoid subsequent transplan-
tation or reimplantation of an assist device.3 Prolonged mechanical
unloading of the failing heart by an LVAD promotes ventricular
recovery (ie, improved cardiothoracic ratio, end-diastolic dimen-
sion, ejection fraction, pulmonary capillary wedge pressure, and
pulmonary vascular resistance and also striking histologic im-
provement of the myocardium).4,5 This unexpected benefit of
prolonged LVAD use has led to another indication for LVAD
support: bridging to recovery. Although this new use of an LVAD
is promising, this case demonstrates that the device might also lead
to unexpected complications, such as the development of a pseu-
doaneurysm.
Typically, pseudoaneurysm of the ascending aorta is thought to
be an unusual and potentially fatal complication of cardiovascular
surgery. Most pseudoaneurysms are associated with aortic valve or
CABG surgery and are often infectious in origin. In several re-
ported series, infected pseudoaneurysms occurred along the aortic
suture lines after cardiac transplantation. However, to our knowl-
edge, there has never been any report of a case of an infected
pseudoaneurysm of the prosthetic graft remnant that remains at-
tached to the ascending aorta after LVAD removal. The only
similar report in the literature is of a pseudoaneurysm of the
outflow graft itself in a patient supported with a Novacor N100 left
ventricular assist system (Baxter Healthcare Corp, Oakland, Cal-
if).1
Figure 1. Surface-shaded rendering of the thoracic aorta in the
lateral projection superimposed on a single sagittal slice of the
chest, as acquired by means of 3-dimensional MRA. The arrow-
heads denote the sternum and show the proximity of the pseu-
doaneurysm (arrow) when considering re-exploration. The twist-
ing line between the pseudoaneurysm and the sternum indicates
the right internal thoracic artery.
Figure 2. CT scan of the chest, taken at 1 year of follow-up,
showing normal findings and confirming that the Dacron repair
graft was still intact.
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Because the ascending aorta has been the preferred site for
arterial cannulation for primary heart operations for the past 2
decades, and because the number of CABG and aortic valvular
procedures involving entry into the ascending aorta has increased,
pseudoaneurysms of the thoracic aorta have become more fre-
quent.6,7 Predisposing factors include graft infection, dissected
native aorta, and possibly tissue necrosis after excessive use of
biologic glue.8 Pseudoaneurysms are the result of disruption of at
least one layer of the vessel wall and are contained by the remain-
ing vascular layers or the surrounding structures of the mediasti-
num with or without development of a neointima. In this respect,
pseudoaneurysms differ from true aneurysms, in which all 3 vas-
cular layers remain intact.9 Although this pseudoaneurysm was the
result of an infection and breakdown of the anastomotic graft
stump, we were able to repair the defect with a prosthetic patch,
with no untoward effects.10
As the present case makes clear, follow-up is essential for
LVAD-supported patients who undergo device removal and are
left with a remnant of the prosthetic graft attached to the ascending
aorta because the remnant has the potential to become a focus of
infection or to develop into a pseudoaneurysm. In cases of medi-
astinal infection in this subgroup of patients, early MRA should be
done because it might easily reveal the presence of a pseudoan-
eurysm. Surgical management is essential in the setting of
pseudoaneurysms after LVAD explantation.
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